IPO Weekly Recap – Pair of IPOs Fail to Come to Market

This past week zero IPOs debuted, ten updated terms and two new deals were filed.

There were two IPOs on the schedule to debut this week, however, neither had the demand needed to successfully come to market. According to the underwriter, the Xtera Communications (Nasdaq: XCOM) deal has been pushed to next week. Please refer to last week’s IPO ratings and subsequent advisories for more information about ‘XCOM’.  Additionally, the GenSight Biologics (Nasdaq: GNST) deal has been postponed due to market conditions per the underwriter.

Looking ahead to this week, there are six new deals on the schedule and we are hearing early, positive interest about ..

SUBSCRIPTION REQUIRED

Week of November 9th IPO Schedule

We did want to point out a high-profile technology deal, Square (NYSE: SQ), set terms for its IPO on Friday and will debut on November 19. As demand grows and the book builds for this deal we will endeavor to provide channel checks to keep clients in the loop as the road-show begins next week.

Please check your emails early and often. We may upgrade or downgrade an IPO and or secondary –sometimes with not as much notice as we would like to give. If you have interest in IPOs do NOT delay your IOI’s (hopefully they are already in)…you can always cancel them. We will keep you posted if and as when…we have anything pertinent to add. The current number of “active” IPOs in the pipeline as of 11/06/15 is 87. Good luck trading!